EGFR and ovarian carcinoma: GALNT14, a member of the acetylgalactosaminyltransferases family, which can regulate the stability of EGFR proteins to inhibit the EGFR/mTOR pathway, has significantly higher levels of GALNT14 in cisplatin resistance ovarian cancer tissue compared to cisplatin sensitive ovarian cancer tissue.